25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Talis Biomedical Corp
Buy, Hold or Sell?

Let's analyze Talis Biomedical Corp together

I guess you are interested in Talis Biomedical Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Talis Biomedical Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Talis Biomedical Corp

I send you an email if I find something interesting about Talis Biomedical Corp.

1. Quick Overview

1.1. Quick analysis of Talis Biomedical Corp (30 sec.)










1.2. What can you expect buying and holding a share of Talis Biomedical Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$26.68
Expected worth in 1 year
$0.60
How sure are you?
5.3%

+ What do you gain per year?

Total Gains per Share
$-26.08
Return On Investment
-1,543.2%

For what price can you sell your share?

Current Price per Share
$1.69
Expected price per share
$1.37 - $2.2
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Talis Biomedical Corp (5 min.)




Live pricePrice per Share (EOD)
$1.69
Intrinsic Value Per Share
$177.39 - $236.98
Total Value Per Share
$204.07 - $263.66

2.2. Growth of Talis Biomedical Corp (5 min.)




Is Talis Biomedical Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$48.6m$121.3m-$57.3m-89.6%

How much money is Talis Biomedical Corp making?

Current yearPrevious yearGrowGrow %
Making money-$12.7m-$5.6m-$7.1m-56.0%
Net Profit Margin-11,851.1%-3,676.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Talis Biomedical Corp (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#165 / 322

Most Revenue
#298 / 322

Most Profit
#270 / 322

Most Efficient
#318 / 322
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Talis Biomedical Corp?

Welcome investor! Talis Biomedical Corp's management wants to use your money to grow the business. In return you get a share of Talis Biomedical Corp.

First you should know what it really means to hold a share of Talis Biomedical Corp. And how you can make/lose money.

Speculation

The Price per Share of Talis Biomedical Corp is $1.69. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Talis Biomedical Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Talis Biomedical Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $26.68. Based on the TTM, the Book Value Change Per Share is $-6.52 per quarter. Based on the YOY, the Book Value Change Per Share is $-11.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Talis Biomedical Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-4.85-287.3%-6.75-399.1%-11.39-673.7%-12.39-733.3%-12.39-733.3%
Usd Book Value Change Per Share-4.42-261.6%-6.52-385.8%-11.09-656.2%1.4083.1%1.4083.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-4.42-261.6%-6.52-385.8%-11.09-656.2%1.4083.1%1.4083.1%
Usd Price Per Share8.66-7.66-0.52-3.64-3.64-
Price to Earnings Ratio-0.45--0.30--0.01--0.08--0.08-
Price-to-Total Gains Ratio-1.96--2.17--0.05--0.71--0.71-
Price to Book Ratio0.32-0.24-0.01-0.06-0.06-
Price-to-Total Gains Ratio-1.96--2.17--0.05--0.71--0.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.69
Number of shares591
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-6.521.40
Usd Total Gains Per Share-6.521.40
Gains per Quarter (591 shares)-3,853.39829.77
Gains per Year (591 shares)-15,413.563,319.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-15414-15424033193309
20-30827-30838066386628
30-46241-46252099579947
40-61654-6166601327613266
50-77068-7708001659516585
60-92481-9249401991519904
70-107895-10790802323423223
80-123308-12332202655326542
90-138722-13873602987229861
100-154136-15415003319133180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.018.00.05.3%1.018.00.05.3%1.018.00.05.3%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%1.016.02.05.3%1.016.02.05.3%1.016.02.05.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.019.00.0%0.00.019.00.0%0.00.019.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%1.016.02.05.3%1.016.02.05.3%1.016.02.05.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Talis Biomedical Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---4.421-6.520+47%-11.089+151%1.404-415%1.404-415%
Book Value Per Share--26.67633.809-21%66.575-60%58.228-54%58.228-54%
Current Ratio--7.7608.681-11%11.271-31%8.704-11%8.704-11%
Debt To Asset Ratio--0.3310.295+12%0.214+55%0.608-46%0.608-46%
Debt To Equity Ratio--0.4950.422+17%0.274+80%0.206+141%0.206+141%
Dividend Per Share----0%-0%-0%-0%
Eps---4.855-6.745+39%-11.386+135%-12.393+155%-12.393+155%
Free Cash Flow Per Share---6.216-5.306-15%-9.124+47%-12.912+108%-12.912+108%
Free Cash Flow To Equity Per Share---6.216-5.306-15%-9.119+47%1.705-465%1.705-465%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--236.980--------
Intrinsic Value_10Y_min--177.390--------
Intrinsic Value_1Y_max---41.808--------
Intrinsic Value_1Y_min---41.104--------
Intrinsic Value_3Y_max---75.655--------
Intrinsic Value_3Y_min---73.235--------
Intrinsic Value_5Y_max---49.270--------
Intrinsic Value_5Y_min---50.031--------
Market Cap3080565.800-413%15788902.27614498364.332+9%955750.097+1552%6741991.503+134%6741991.503+134%
Net Profit Margin----118.5110%-36.7640%-32063.5690%-32063.5690%
Operating Margin----128.3890%-202.9750%-31857.9070%-31857.9070%
Operating Ratio---111.904-100%195.891-100%32077.658-100%32077.658-100%
Pb Ratio0.063-413%0.3250.241+35%0.008+3988%0.064+404%0.064+404%
Pe Ratio-0.087+80%-0.446-0.303-32%-0.012-97%-0.085-81%-0.085-81%
Price Per Share1.690-413%8.6627.658+13%0.524+1552%3.636+138%3.636+138%
Price To Free Cash Flow Ratio-0.068+80%-0.348-0.388+11%-0.014-96%-0.112-68%-0.112-68%
Price To Total Gains Ratio-0.382+80%-1.959-2.173+11%-0.050-97%-0.709-64%-0.709-64%
Quick Ratio--7.3048.475-14%10.937-33%8.065-9%8.065-9%
Return On Assets---0.122-0.141+16%-0.043-64%-0.158+30%-0.158+30%
Return On Equity---0.182-0.200+10%-0.050-72%-0.104-43%-0.104-43%
Total Gains Per Share---4.421-6.520+47%-11.089+151%1.404-415%1.404-415%
Usd Book Value--48626000.00063995500.000-24%121353750.000-60%106636947.368-54%106636947.368-54%
Usd Book Value Change Per Share---4.421-6.520+47%-11.089+151%1.404-415%1.404-415%
Usd Book Value Per Share--26.67633.809-21%66.575-60%58.228-54%58.228-54%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---4.855-6.745+39%-11.386+135%-12.393+155%-12.393+155%
Usd Free Cash Flow---11330000.000-10058750.000-11%-16630500.000+47%-23617105.263+108%-23617105.263+108%
Usd Free Cash Flow Per Share---6.216-5.306-15%-9.124+47%-12.912+108%-12.912+108%
Usd Free Cash Flow To Equity Per Share---6.216-5.306-15%-9.119+47%1.705-465%1.705-465%
Usd Market Cap3080565.800-413%15788902.27614498364.332+9%955750.097+1552%6741991.503+134%6741991.503+134%
Usd Price Per Share1.690-413%8.6627.658+13%0.524+1552%3.636+138%3.636+138%
Usd Profit---8849000.000-12756500.000+44%-5614750.000-37%-22324789.474+152%-22324789.474+152%
Usd Revenue---75000.000-100%255500.000-100%298002.895-100%298002.895-100%
Usd Total Gains Per Share---4.421-6.520+47%-11.089+151%1.404-415%1.404-415%
 EOD+3 -5MRQTTM+15 -16YOY+17 -145Y+14 -1710Y+14 -17

3.3 Fundamental Score

Let's check the fundamental score of Talis Biomedical Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.087
Price to Book Ratio (EOD)Between0-10.063
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.304
Current Ratio (MRQ)Greater than17.760
Debt to Asset Ratio (MRQ)Less than10.331
Debt to Equity Ratio (MRQ)Less than10.495
Return on Equity (MRQ)Greater than0.15-0.182
Return on Assets (MRQ)Greater than0.05-0.122
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Talis Biomedical Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.228
Ma 20Greater thanMa 501.721
Ma 50Greater thanMa 1001.769
Ma 100Greater thanMa 2004.135
OpenGreater thanClose1.690
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Talis Biomedical Corp

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

Fundamental data was last updated by Penke on 2024-11-24 00:09:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Talis Biomedical Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Talis Biomedical Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11,851.1%+11,851.1%
TTM-11,851.1%YOY-3,676.4%-8,174.7%
TTM-11,851.1%5Y-3,206,356.9%+3,194,505.8%
5Y-3,206,356.9%10Y-3,206,356.9%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.4%+6.4%
TTM-11,851.1%-15.3%-11,835.8%
YOY-3,676.4%-15.2%-3,661.2%
5Y-3,206,356.9%-18.1%-3,206,338.8%
10Y-3,206,356.9%-23.4%-3,206,333.5%
4.3.1.2. Return on Assets

Shows how efficient Talis Biomedical Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • -12.2% Return on Assets means that Talis Biomedical Corp generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Talis Biomedical Corp:

  • The MRQ is -12.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-14.1%+1.9%
TTM-14.1%YOY-4.3%-9.7%
TTM-14.1%5Y-15.8%+1.8%
5Y-15.8%10Y-15.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-2.1%-10.1%
TTM-14.1%-3.2%-10.9%
YOY-4.3%-4.0%-0.3%
5Y-15.8%-3.0%-12.8%
10Y-15.8%-4.1%-11.7%
4.3.1.3. Return on Equity

Shows how efficient Talis Biomedical Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • -18.2% Return on Equity means Talis Biomedical Corp generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Talis Biomedical Corp:

  • The MRQ is -18.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.2%TTM-20.0%+1.8%
TTM-20.0%YOY-5.0%-14.9%
TTM-20.0%5Y-10.4%-9.6%
5Y-10.4%10Y-10.4%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.2%-2.4%-15.8%
TTM-20.0%-3.8%-16.2%
YOY-5.0%-4.2%-0.8%
5Y-10.4%-4.4%-6.0%
10Y-10.4%-5.7%-4.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Talis Biomedical Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Talis Biomedical Corp is operating .

  • Measures how much profit Talis Biomedical Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Talis Biomedical Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-12,838.9%+12,838.9%
TTM-12,838.9%YOY-20,297.5%+7,458.6%
TTM-12,838.9%5Y-3,185,790.7%+3,172,951.8%
5Y-3,185,790.7%10Y-3,185,790.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--10.8%+10.8%
TTM-12,838.9%-16.8%-12,822.1%
YOY-20,297.5%-13.0%-20,284.5%
5Y-3,185,790.7%-17.4%-3,185,773.3%
10Y-3,185,790.7%-19.8%-3,185,770.9%
4.3.2.2. Operating Ratio

Measures how efficient Talis Biomedical Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Talis Biomedical Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM111.904-111.904
TTM111.904YOY195.891-83.987
TTM111.9045Y32,077.658-31,965.753
5Y32,077.65810Y32,077.6580.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.324-1.324
TTM111.9041.340+110.564
YOY195.8911.326+194.565
5Y32,077.6581.373+32,076.285
10Y32,077.6581.321+32,076.337
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Talis Biomedical Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Talis Biomedical Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.76 means the company has $7.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Talis Biomedical Corp:

  • The MRQ is 7.760. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.681. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.760TTM8.681-0.921
TTM8.681YOY11.271-2.589
TTM8.6815Y8.704-0.023
5Y8.70410Y8.7040.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7602.573+5.187
TTM8.6812.666+6.015
YOY11.2712.922+8.349
5Y8.7043.393+5.311
10Y8.7043.470+5.234
4.4.3.2. Quick Ratio

Measures if Talis Biomedical Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • A Quick Ratio of 7.30 means the company can pay off $7.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Talis Biomedical Corp:

  • The MRQ is 7.304. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.475. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.304TTM8.475-1.170
TTM8.475YOY10.937-2.462
TTM8.4755Y8.065+0.410
5Y8.06510Y8.0650.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3041.528+5.776
TTM8.4751.698+6.777
YOY10.9371.875+9.062
5Y8.0652.296+5.769
10Y8.0652.545+5.520
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Talis Biomedical Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Talis Biomedical Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Talis Biomedical Corp to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.33 means that Talis Biomedical Corp assets are financed with 33.1% credit (debt) and the remaining percentage (100% - 33.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Talis Biomedical Corp:

  • The MRQ is 0.331. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.295. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.331TTM0.295+0.036
TTM0.295YOY0.214+0.081
TTM0.2955Y0.608-0.313
5Y0.60810Y0.6080.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3310.407-0.076
TTM0.2950.398-0.103
YOY0.2140.360-0.146
5Y0.6080.437+0.171
10Y0.6080.457+0.151
4.5.4.2. Debt to Equity Ratio

Measures if Talis Biomedical Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • A Debt to Equity ratio of 49.5% means that company has $0.50 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Talis Biomedical Corp:

  • The MRQ is 0.495. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.422. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.422+0.073
TTM0.422YOY0.274+0.148
TTM0.4225Y0.206+0.216
5Y0.20610Y0.2060.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4950.552-0.057
TTM0.4220.589-0.167
YOY0.2740.530-0.256
5Y0.2060.630-0.424
10Y0.2060.698-0.492
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Talis Biomedical Corp generates.

  • Above 15 is considered overpriced but always compare Talis Biomedical Corp to the Medical Devices industry mean.
  • A PE ratio of -0.45 means the investor is paying $-0.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Talis Biomedical Corp:

  • The EOD is -0.087. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.446. Based on the earnings, the company is expensive. -2
  • The TTM is -0.303. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.087MRQ-0.446+0.359
MRQ-0.446TTM-0.303-0.143
TTM-0.303YOY-0.012-0.291
TTM-0.3035Y-0.085-0.218
5Y-0.08510Y-0.0850.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.087-1.069+0.982
MRQ-0.446-1.360+0.914
TTM-0.303-1.961+1.658
YOY-0.012-2.324+2.312
5Y-0.085-2.115+2.030
10Y-0.085-2.205+2.120
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Talis Biomedical Corp:

  • The EOD is -0.068. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.348. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.388. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.068MRQ-0.348+0.280
MRQ-0.348TTM-0.388+0.040
TTM-0.388YOY-0.014-0.374
TTM-0.3885Y-0.112-0.276
5Y-0.11210Y-0.1120.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.068-1.388+1.320
MRQ-0.348-1.767+1.419
TTM-0.388-2.060+1.672
YOY-0.014-5.503+5.489
5Y-0.112-3.739+3.627
10Y-0.112-4.711+4.599
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Talis Biomedical Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.32 means the investor is paying $0.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Talis Biomedical Corp:

  • The EOD is 0.063. Based on the equity, the company is cheap. +2
  • The MRQ is 0.325. Based on the equity, the company is cheap. +2
  • The TTM is 0.241. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.063MRQ0.325-0.261
MRQ0.325TTM0.241+0.084
TTM0.241YOY0.008+0.233
TTM0.2415Y0.064+0.176
5Y0.06410Y0.0640.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.0632.148-2.085
MRQ0.3252.144-1.819
TTM0.2412.339-2.098
YOY0.0083.045-3.037
5Y0.0644.091-4.027
10Y0.0644.612-4.548
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Talis Biomedical Corp.

4.8.1. Institutions holding Talis Biomedical Corp

Institutions are holding 41.988% of the shares of Talis Biomedical Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30BML Capital Management LLC13.64380.2707248702205959481.8543
2024-06-30Springbok Capital Management, LLC0.8190.0091492800
2024-06-30Geode Capital Management, LLC0.7691014020213017.9142
2024-06-30Susquehanna International Group, LLP0.6368011607-5824-33.4117
2024-06-30BlackRock Inc0.234304271-440-9.3398
2024-06-30Tower Research Capital LLC0.04810.0001877-50-5.3937
2024-06-30Morgan Stanley - Brokerage Accounts0.00950174-1096-86.2992
2024-06-30Steward Partners Investment Advisory, LLC0.008101471470
2024-06-30Advisor Group Holdings, Inc.0.0046084-38-31.1475
2024-06-30Larson Financial Group, LLC0.000801400
2024-06-30Bank of America Corp0.0007013130
2024-06-30UBS Group AG0.0006011-109-90.8333
2024-06-30JPMorgan Chase & Co0.00020300
2024-06-30Qube Research & Technologies0.00010200
2024-06-30ADAR1 Capital Management LLC000-300-100
2024-06-30Wells Fargo & Co000-13-100
2024-09-30Baker Bros Advisors LP000-508323-100
2024-09-30Renaissance Technologies Corp000-12299-100
2024-09-30Vanguard Group Inc000-31013-100
Total 16.17570.2798294853-351256-119.1%

4.9.2. Funds holding Talis Biomedical Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30BlackRock Event Driven Equity Instl0.0308056100
2024-06-30SSgA U.S. Total Market Index Strategy0.009201675042.735
2024-08-31Guggenheim Active Allocation Fund0.00030600
Total 0.04030734+50+6.8%

5.3. Insider Transactions

Insiders are holding 8.306% of the shares of Talis Biomedical Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-09-03Braden Michael LeonardBUY5004
2024-08-30Braden Michael LeonardBUY1514.25
2024-08-28Braden Michael LeonardBUY12153.96
2024-08-26Braden Michael LeonardBUY131673.9
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Other Current Liabilities  4,035-1,1432,8921,6594,551-1,6012,950-4,390-1,440



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets72,699
Total Liabilities24,073
Total Stockholder Equity48,626
 As reported
Total Liabilities 24,073
Total Stockholder Equity+ 48,626
Total Assets = 72,699

Assets

Total Assets72,699
Total Current Assets63,601
Long-term Assets9,098
Total Current Assets
Cash And Cash Equivalents 59,867
Other Current Assets 3,734
Total Current Assets  (as reported)63,601
Total Current Assets  (calculated)63,601
+/-0
Long-term Assets
Property Plant Equipment 8,332
Other Assets 0
Long-term Assets  (as reported)9,098
Long-term Assets  (calculated)8,332
+/- 766

Liabilities & Shareholders' Equity

Total Current Liabilities8,196
Long-term Liabilities15,877
Total Stockholder Equity48,626
Total Current Liabilities
Short-term Debt 5,846
Accounts payable 3,790
Other Current Liabilities -1,440
Total Current Liabilities  (as reported)8,196
Total Current Liabilities  (calculated)8,196
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt12,954
Long-term Liabilities  (as reported)15,877
Long-term Liabilities  (calculated)12,954
+/- 2,923
Total Stockholder Equity
Retained Earnings -561,845
Other Stockholders Equity 610,468
Total Stockholder Equity (as reported)48,626
Total Stockholder Equity (calculated)48,623
+/- 3
Other
Capital Stock3
Cash and Short Term Investments 59,867
Common Stock Shares Outstanding 1,822
Current Deferred Revenue-3,557
Liabilities and Stockholders Equity 72,699
Net Debt -41,067
Net Invested Capital 48,623
Net Working Capital 55,405
Property Plant and Equipment Gross 8,332
Short Long Term Debt Total 18,800



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
25,733
0
0
115,252
198,405
403,182
379,538
303,096
265,828
230,587
221,690
194,094
169,290
133,053
123,076
107,228
98,340
82,494
72,699
72,69982,49498,340107,228123,076133,053169,290194,094221,690230,587265,828303,096379,538403,182198,405115,2520025,733
   > Total Current Assets 
24,107
0
0
106,004
188,724
391,322
353,865
277,557
236,115
200,822
173,966
150,377
133,282
115,588
101,965
89,532
77,683
71,170
63,601
63,60171,17077,68389,532101,965115,588133,282150,377173,966200,822236,115277,557353,865391,322188,724106,0040024,107
       Cash And Cash Equivalents 
21,604
0
0
55,406
138,483
348,012
313,458
273,603
232,545
187,586
165,373
143,783
130,191
112,959
98,200
87,996
76,732
70,337
59,867
59,86770,33776,73287,99698,200112,959130,191143,783165,373187,586232,545273,603313,458348,012138,48355,4060021,604
       Net Receivables 
1,806
0
0
334
471
0
117
219
183
2,599
636
433
308
127
532
5
50
6
0
065055321273084336362,5991832191170471334001,806
       Other Current Assets 
697
0
0
1,393
3,106
3,448
3,209
2,797
3,387
7,138
5,738
4,134
2,783
1,492
2,223
1,531
901
827
3,734
3,7348279011,5312,2231,4922,7834,1345,7387,1383,3872,7973,2093,4483,1061,39300697
   > Long-term Assets 
1,626
0
0
9,248
9,681
11,860
25,673
25,539
29,713
29,765
47,724
43,717
36,008
17,465
21,111
17,696
20,657
11,324
9,098
9,09811,32420,65717,69621,11117,46536,00843,71747,72429,76529,71325,53925,67311,8609,6819,248001,626
       Property Plant Equipment 
1,535
0
0
9,157
9,681
10,112
23,925
23,791
23,435
23,458
45,948
41,941
34,232
15,923
19,569
16,154
15,449
9,782
8,332
8,3329,78215,44916,15419,56915,92334,23241,94145,94823,45823,43523,79123,92510,1129,6819,157001,535
       Other Assets 
91
0
0
0
567
1,748
1,748
1,748
6,278
6,307
1,776
1,776
1,776
0
1,542
0
0
0
0
00001,54201,7761,7761,7766,3076,2781,7481,7481,74856700091
> Total Liabilities 
46,873
0
0
181,194
306,976
46,849
85,806
44,304
31,851
27,802
44,671
41,708
42,551
22,929
26,910
25,672
29,224
25,810
24,073
24,07325,81029,22425,67226,91022,92942,55141,70844,67127,80231,85144,30485,80646,849306,976181,1940046,873
   > Total Current Liabilities 
4,037
0
0
13,717
16,026
46,849
72,629
31,342
19,106
15,276
13,903
11,378
12,672
11,180
9,262
8,450
8,772
9,471
8,196
8,1969,4718,7728,4509,26211,18012,67211,37813,90315,27619,10631,34272,62946,84916,02613,717004,037
       Short-term Debt 
0
0
0
825
693
491
882
1,125
1,232
1,628
2,334
2,995
3,703
2,962
2,736
2,861
2,882
2,902
5,846
5,8462,9022,8822,8612,7362,9623,7032,9952,3341,6281,2321,125882491693825000
       Accounts payable 
1,566
0
0
3,958
4,906
10,826
11,695
5,388
5,122
5,263
3,978
4,111
3,768
3,871
2,491
2,697
1,339
3,619
3,790
3,7903,6191,3392,6972,4913,8713,7684,1113,9785,2635,1225,38811,69510,8264,9063,958001,566
       Other Current Liabilities 
2,471
0
0
8,934
721
864
709
983
1,080
8,385
7,591
4,272
5,201
4,347
4,035
2,892
4,551
2,950
-1,440
-1,4402,9504,5512,8924,0354,3475,2014,2727,5918,3851,0809837098647218,934002,471
   > Long-term Liabilities 
42,836
0
0
167,477
290,950
5
13,177
12,962
12,745
12,526
30,768
30,330
29,879
11,749
17,648
17,222
20,452
16,339
15,877
15,87716,33920,45217,22217,64811,74929,87930,33030,76812,52612,74512,96213,1775290,950167,4770042,836
       Other Liabilities 
81
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000081
> Total Stockholder Equity
-21,140
0
0
-65,942
-108,571
356,333
293,732
258,792
233,977
202,785
177,019
152,386
126,739
110,124
96,166
81,556
69,116
56,684
48,626
48,62656,68469,11681,55696,166110,124126,739152,386177,019202,785233,977258,792293,732356,333-108,571-65,94200-21,140
   Common Stock
0
0
0
0
0
2
2
2
3
3
3
3
3
3
0
0
0
0
0
0000033333322200000
   Retained Earnings -561,845-552,996-539,961-526,501-510,819-495,785-477,954-451,025-425,004-397,993-364,942-336,288-297,870-233,398-172,906-128,71000-81,776
   Accumulated Other Comprehensive Income 00000000000-3000-2,79900-2,235
   Capital Surplus 
0
0
0
0
0
589,726
591,597
595,075
0
0
0
0
0
0
0
0
0
0
0
00000000000595,075591,597589,72600000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
62,871
0
0
65,567
64,335
589,726
591,597
595,078
598,913
600,772
602,017
603,405
604,687
605,903
606,982
608,054
609,074
609,677
610,468
610,468609,677609,074608,054606,982605,903604,687603,405602,017600,772598,913595,078591,597589,72664,33565,5670062,871



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue412
Cost of Revenue-41
Gross Profit371371
 
Operating Income (+$)
Gross Profit371
Operating Expense-67,186
Operating Income-66,815-66,815
 
Operating Expense (+$)
Research Development40,694
Selling General Administrative32,408
Selling And Marketing Expenses0
Operating Expense67,18673,102
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-66,815
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-62,007-71,623
EBIT - interestExpense = -66,815
-57,101
-62,007
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-66,815-62,007
Earnings Before Interest and Taxes (EBITDA)-66,045
 
After tax Income (+$)
Income Before Tax-62,007
Tax Provision-0
Net Income From Continuing Ops-75,476-62,007
Net Income-62,007
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,227
Total Other Income/Expenses Net4,8080
 

Technical Analysis of Talis Biomedical Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Talis Biomedical Corp. The general trend of Talis Biomedical Corp is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Talis Biomedical Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Talis Biomedical Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.91 < 1.95 < 2.2.

The bearish price targets are: 1.57 > 1.56 > 1.37.

Tweet this
Talis Biomedical Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Talis Biomedical Corp. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Talis Biomedical Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Talis Biomedical Corp. The current macd is -0.06739536.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Talis Biomedical Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Talis Biomedical Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Talis Biomedical Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Talis Biomedical Corp Daily Moving Average Convergence/Divergence (MACD) ChartTalis Biomedical Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Talis Biomedical Corp. The current adx is 10.77.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Talis Biomedical Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Talis Biomedical Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Talis Biomedical Corp. The current sar is 1.61170614.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Talis Biomedical Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Talis Biomedical Corp. The current rsi is 42.23. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Talis Biomedical Corp Daily Relative Strength Index (RSI) ChartTalis Biomedical Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Talis Biomedical Corp. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Talis Biomedical Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Talis Biomedical Corp Daily Stochastic Oscillator ChartTalis Biomedical Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Talis Biomedical Corp. The current cci is -50.94348187.

Talis Biomedical Corp Daily Commodity Channel Index (CCI) ChartTalis Biomedical Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Talis Biomedical Corp. The current cmo is -13.2715397.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Talis Biomedical Corp Daily Chande Momentum Oscillator (CMO) ChartTalis Biomedical Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Talis Biomedical Corp. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Talis Biomedical Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Talis Biomedical Corp Daily Williams %R ChartTalis Biomedical Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Talis Biomedical Corp.

Talis Biomedical Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Talis Biomedical Corp. The current atr is 0.10506487.

Talis Biomedical Corp Daily Average True Range (ATR) ChartTalis Biomedical Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Talis Biomedical Corp. The current obv is 105,562.

Talis Biomedical Corp Daily On-Balance Volume (OBV) ChartTalis Biomedical Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Talis Biomedical Corp. The current mfi is 40.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Talis Biomedical Corp Daily Money Flow Index (MFI) ChartTalis Biomedical Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Talis Biomedical Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Talis Biomedical Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Talis Biomedical Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.228
Ma 20Greater thanMa 501.721
Ma 50Greater thanMa 1001.769
Ma 100Greater thanMa 2004.135
OpenGreater thanClose1.690
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Talis Biomedical Corp with someone you think should read this too:
  • Are you bullish or bearish on Talis Biomedical Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Talis Biomedical Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Talis Biomedical Corp

I send you an email if I find something interesting about Talis Biomedical Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Talis Biomedical Corp.

Receive notifications about Talis Biomedical Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.